The long-term effect of bendroflumethiazide on renal calcium and magnesium excretion and stone formation in patients with recurring renal stones.
D000328:Adult; D000368:Aged; D001539:Bendroflumethiazide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood / Q000652:urine*; D002245:Carbon Dioxide / Q000097:blood; D002712:Chlorides / Q000097:blood; D007172:Erectile Dysfunction / Q000139:chemically induced; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008274:Magnesium / Q000097:blood / Q000652:urine*; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000097:blood; D011859:Radiography; D012964:Sodium / Q000097:blood; D013997:Time Factors; D014527:Uric Acid / Q000097:blood
D002712:Chlorides; D002245:Carbon Dioxide; D014527:Uric Acid; D001539:Bendroflumethiazide; D012964:Sodium; D008274:Magnesium; D011188:Potassium; D002118:Calcium